Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03983668
Title CMP-001 for Relapsed and Refractory Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Umar Farooq
Indications

non-Hodgkin lymphoma

Hodgkin's lymphoma

Therapies

Pembrolizumab + Vidutolimod

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.